Incyte Corp (INCY)
70.39
-0.66
(-0.93%)
USD |
NASDAQ |
Nov 21, 16:00
70.35
-0.04
(-0.06%)
After-Hours: 20:00
Incyte Gross Profit Margin (Quarterly): 92.44% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 92.44% |
| June 30, 2024 | 92.66% |
| March 31, 2024 | 93.08% |
| December 31, 2023 | 93.11% |
| September 30, 2023 | 93.46% |
| June 30, 2023 | 92.85% |
| March 31, 2023 | 92.98% |
| December 31, 2022 | 93.61% |
| September 30, 2022 | 93.37% |
| June 30, 2022 | 94.45% |
| March 31, 2022 | 94.19% |
| December 31, 2021 | 94.91% |
| September 30, 2021 | 95.09% |
| June 30, 2021 | 94.62% |
| March 31, 2021 | 95.17% |
| December 31, 2020 | 95.40% |
| September 30, 2020 | 94.47% |
| June 30, 2020 | 95.15% |
| March 31, 2020 | 95.20% |
| December 31, 2019 | 94.43% |
| September 30, 2019 | 94.56% |
| June 30, 2019 | 94.45% |
| March 31, 2019 | 95.46% |
| December 31, 2018 | 95.01% |
| September 30, 2018 | 94.49% |
| Date | Value |
|---|---|
| June 30, 2018 | 95.23% |
| March 31, 2018 | 95.26% |
| December 31, 2017 | 94.97% |
| September 30, 2017 | 94.22% |
| June 30, 2017 | 93.79% |
| March 31, 2017 | 96.14% |
| December 31, 2016 | 93.99% |
| September 30, 2016 | 92.50% |
| June 30, 2016 | 94.98% |
| March 31, 2016 | 97.72% |
| December 31, 2015 | 96.01% |
| September 30, 2015 | 95.71% |
| June 30, 2015 | 96.16% |
| March 31, 2015 | 98.13% |
| December 31, 2014 | 98.04% |
| September 30, 2014 | 99.89% |
| June 30, 2014 | 99.81% |
| March 31, 2014 | 99.81% |
| December 31, 2013 | 99.83% |
| September 30, 2013 | 99.82% |
| June 30, 2013 | 99.85% |
| March 31, 2013 | 99.79% |
| December 31, 2012 | 99.91% |
| September 30, 2012 | 99.95% |
| June 30, 2012 | 99.98% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
92.44%
Minimum
Sep 2024
95.40%
Maximum
Dec 2020
94.03%
Average
94.31%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Syndax Pharmaceuticals Inc | -- |
| Allogene Therapeutics Inc | -- |
| Arcutis Biotherapeutics Inc | 87.70% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.75% |
| Return on Assets | 0.54% |
| Return on Invested Capital | 0.75% |
| Profit Margin (Quarterly) | 9.36% |
| Operating Margin (Quarterly) | 14.90% |
| Return on Net Operating Assets | 1.76% |